{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Vicarious Surgical, Inc. technically bullish or bearish?
As of May 27, 2025, Vicarious Surgical, Inc. is in a mildly bearish trend, indicated by daily moving averages and Bollinger Bands, despite some mildly bullish signals from MACD and KST.
Who are in the management team of Vicarious Surgical, Inc.?
As of March 2022, the management team of Vicarious Surgical, Inc. includes President and Director Donald Tang, CEO and Director David Chu, and directors Michael Kives, Fred Langhammer, and Terry Lundgren.
What does Vicarious Surgical, Inc. do?
Vicarious Surgical, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $15 million and a market cap of $45.44 million. It has no dividend yield and negative key financial metrics, including a debt equity ratio of -1.06 and a return on equity of -186.15%.
How big is Vicarious Surgical, Inc.?
As of Jun 18, Vicarious Surgical, Inc. has a market capitalization of 45.44 million and reported net sales of 0.00 million with a net profit of -61.62 million over the last four quarters. The balance sheet shows shareholder's funds of 46.70 million and total assets of 67.72 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
